日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clonal Hematopoiesis Risk Score (CHRS) Evaluation as a Prognostic Marker for Death in Cardio-Oncology Cohort

克隆性造血风险评分(CHRS)作为心脏肿瘤患者队列死亡预后标志物的评估

Singh, Jaiveer; Chehayeb, Rachel Jaber; Im, Yunju; Yi, Irvin; El Zarif, Talal; Guajardo, Ana Ferrigno; VanOudenhove, Jennifer; Halene, Stephanie; Jha, Alok; Kwan, Jennifer M

Clonal hematopoiesis of indeterminate potential is associated with increased risk of immune checkpoint inhibitor myocarditis in a prospective study of a cardio-oncology cohort

一项针对心脏肿瘤患者队列的前瞻性研究表明,具有不确定潜能的克隆性造血与免疫检查点抑制剂心肌炎风险增加相关。

Jaber Chehayeb, Rachel; Singh, Jaiveer; Matute-Martinez, Carlos; Chen, Nathan W; Guajardo, Ana Ferrigno; Lin, Derrick; Jayakrishnan, Ritujith; Christofides, Anthos; Leveille, Etienne; Im, Yunju; Biancon, Giulia; VanOudenhove, Jennifer; Ibrahim, Eiman; Ardasheva, Anastasias; Jha, Alokkumar; Hwa, John; Halene, Stephanie; Kwan, Jennifer M